{"title":"Featured Collection","description":"","products":[{"product_id":"kpv","title":"KPV","description":"\u003c!-- =========================================================\n  KPV — DISSOLV LABS\n  10 mg lyophilized vial\n  Recovery category\n  Shopify product description — paste into the Code View\n  of the product description field.\n========================================================= --\u003e\n\u003ch2\u003eKPV — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eKPV is a synthetic tripeptide referenced in the scientific literature as the C-terminal three-amino-acid fragment of \u003cstrong\u003eα-melanocyte-stimulating hormone (α-MSH)\u003c\/strong\u003e. Composed of the sequence \u003cstrong\u003elysine–proline–valine\u003c\/strong\u003e, it is studied within the broader category of inflammatory signaling and immunomodulatory research peptides. DISSOLV LABS supplies KPV as a \u003cstrong\u003e10 mg\u003c\/strong\u003e lyophilized vial — a high-purity analytical reference compound for qualified laboratory research professionals.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\u003cstrong\u003eFormat:\u003c\/strong\u003e 10 mg lyophilized vial\u003cbr\u003e\u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\u003c\/p\u003e\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eKPV is the tripeptide sequence \u003cstrong\u003eLys-Pro-Val\u003c\/strong\u003e, corresponding to the C-terminal three residues (positions 11–13) of α-melanocyte-stimulating hormone. Within the published literature, KPV is classified as an α-MSH-derived signaling tripeptide and is studied as a reference compound for research involving inflammatory pathway modulation, NF-κB signaling, and cytokine expression profiling.\u003c\/p\u003e\n\u003cp\u003eKPV is structurally and mechanistically distinct from larger regenerative peptides such as BPC-157 and TB-500, and from copper-binding tripeptides such as GHK-Cu. Within the Recovery research peptide category, KPV occupies a unique position as the principal \u003cstrong\u003eα-MSH-derived tripeptide reference standard\u003c\/strong\u003e for inflammatory signaling pathway research.\u003c\/p\u003e\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eKPV has been investigated in published preclinical research and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNF-κB signaling pathway research\u003c\/li\u003e\n\u003cli\u003eCytokine expression and inflammatory mediator profiling\u003c\/li\u003e\n\u003cli\u003eMelanocortin pathway and α-MSH fragment structure–activity research\u003c\/li\u003e\n\u003cli\u003eIntestinal epithelial pathway and IBD research models\u003c\/li\u003e\n\u003cli\u003eDermal and mucosal inflammatory signaling research\u003c\/li\u003e\n\u003cli\u003eComparative tripeptide structure–activity profiling\u003c\/li\u003e\n\u003cli\u003eCombination peptide research with regenerative pathway compounds\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eKPV\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAlternative designations\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLys-Pro-Val · α-MSH (11–13) · α-MSH C-terminal tripeptide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic tripeptide (α-MSH-derived fragment)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAmino acid sequence\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLysine – Proline – Valine (Lys-Pro-Val)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eInflammatory signaling research peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eα-MSH-derived signaling tripeptides\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSource peptide\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eα-melanocyte-stimulating hormone (α-MSH)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eInflammatory signaling, NF-κB pathway research, cytokine profiling, melanocortin pathway research, mucosal biology\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBPC-157, TB-500, BPC-157 \/ TB-500 research stack, GHK-Cu\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery KPV lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e10 mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-KPV-010\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat is KPV?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eKPV is a synthetic tripeptide referenced in scientific literature as the C-terminal three-amino-acid fragment of α-melanocyte-stimulating hormone (α-MSH). It is composed of the sequence lysine-proline-valine and is studied within the broader category of inflammatory signaling and immunomodulatory research peptides. Supplied by DISSOLV LABS as an analytical reference compound for laboratory research use only.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat does KPV stand for?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eKPV refers to the tripeptide sequence \u003cstrong\u003eLysine–Proline–Valine\u003c\/strong\u003e, using the single-letter amino acid codes K (Lys), P (Pro), and V (Val). It is also referenced in the literature as \u003cstrong\u003eα-MSH (11–13)\u003c\/strong\u003e, denoting its position as the C-terminal residues of α-melanocyte-stimulating hormone.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat is the amino acid sequence of KPV?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe peptide is composed of three amino acids in sequence: \u003cstrong\u003elysine, proline, and valine\u003c\/strong\u003e (Lys-Pro-Val), corresponding to positions 11, 12, and 13 of the parent α-MSH peptide.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat is the relationship between KPV and α-MSH?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eα-melanocyte-stimulating hormone (α-MSH) is a naturally occurring 13-amino-acid peptide. KPV represents the C-terminal three-residue fragment of α-MSH (positions 11–13) and is studied in the literature as a minimal active sequence within the α-MSH structure–activity framework.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat vial size is available?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eDISSOLV LABS supplies KPV as a \u003cstrong\u003e10 mg\u003c\/strong\u003e lyophilized vial (catalog DSL-KPV-010), produced from ≥99% purity reference material and accompanied by a per-lot Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat category does KPV belong to?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eKPV is classified within the α-MSH-derived signaling tripeptide family and studied as the principal α-MSH-derived tripeptide reference compound within the broader Recovery research peptide category. It is referenced alongside BPC-157, TB-500, and GHK-Cu in regenerative and inflammatory pathway research literature.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eHow does KPV differ from BPC-157 and TB-500?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eIn published research literature, KPV is described as an α-MSH-derived tripeptide studied in inflammatory signaling and NF-κB pathway research; BPC-157 is a body protection compound-derived pentadecapeptide studied in connective tissue and gastrointestinal pathway research; and TB-500 is a Thymosin Beta-4 active fragment studied in actin-binding and cellular migration research. Each compound occupies a distinct position within the broader Recovery research peptide category.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eHow does KPV differ from GHK-Cu?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eKPV and GHK-Cu are both tripeptides studied within the Recovery research category, but they are structurally and mechanistically distinct. KPV is an α-MSH-derived tripeptide (Lys-Pro-Val) studied in inflammatory signaling research, while GHK-Cu is a copper-binding tripeptide (Gly-His-Lys + Cu²⁺) studied in extracellular matrix and dermal remodeling research.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eDISSOLV LABS supplies KPV at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eEach KPV lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eHow should KPV be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eHow is KPV reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eKPV is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eIs KPV research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eYes. KPV supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat compounds are related to KPV?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eKPV is commonly referenced alongside BPC-157, TB-500, BPC-157 \/ TB-500 combination research stacks, and GHK-Cu — all of which are studied within tissue repair, regenerative pathway, and inflammatory signaling research domains.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWho should handle KPV?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eKPV is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157\u003c\/strong\u003e — body protection compound-derived pentadecapeptide research peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500\u003c\/strong\u003e — Thymosin Beta-4 active fragment research peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157 \/ TB-500 Research Stack\u003c\/strong\u003e — combination research preparation pairing BPC-157 with TB-500\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e — copper-binding tripeptide research compound (glycyl-L-histidyl-L-lysine + Cu²⁺)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"Dissolv Labs","offers":[{"title":"Default Title","offer_id":52101847318808,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/KPV10mg.png?v=1779622002"},{"product_id":"glow-stack","title":"Glow Stack","description":"\u003c!-- =========================================================\n  GLOW STACK — DISSOLV LABS\n  Blended research peptide formulation:\n  GHK-Cu + BPC-157 + TB-500\n  Single lyophilized vial\n  Shopify product description — paste into the Code View\n  of the product description field.\n========================================================= --\u003e\n\u003ch2\u003eGlow Stack — Blended Research Peptide Formulation\u003c\/h2\u003e\n\u003cp\u003eThe DISSOLV LABS \u003cstrong\u003eGlow Stack\u003c\/strong\u003e is a co-formulated research peptide blend combining three of the most extensively profiled compounds within the regenerative-pathway and extracellular-matrix research literature: \u003cstrong\u003eGHK-Cu\u003c\/strong\u003e (copper tripeptide), \u003cstrong\u003eBPC-157\u003c\/strong\u003e (pentadecapeptide), and \u003cstrong\u003eTB-500\u003c\/strong\u003e (synthetic thymosin beta-4 fragment). Supplied as a single lyophilized vial for qualified laboratory research professionals.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eComposition:\u003c\/strong\u003e GHK-Cu · BPC-157 · TB-500\u003cbr\u003e\u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% per component (HPLC-MS verified)\u003cbr\u003e\u003cstrong\u003eFormat:\u003c\/strong\u003e Single co-lyophilized blended vial\u003cbr\u003e\u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\u003c\/p\u003e\n\u003ch2\u003eFormulation Overview\u003c\/h2\u003e\n\u003cp\u003eThe Glow Stack is a deliberately co-formulated research blend. Each component is a synthetic peptide individually referenced in the scientific literature across complementary research domains — copper-peptide signaling, regenerative pathway research, and thymosin fragment research — and is supplied here as a single blended lyophilizate to streamline comparative laboratory work.\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCopper-binding tripeptide (Gly-His-Lys-Cu²⁺); referenced in extracellular matrix and tissue signaling research literature.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic pentadecapeptide (15 amino acids) derived from a sequence in body protection compound; commonly studied in regenerative pathway and gastrointestinal research models.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide fragment of Thymosin Beta-4 (Tβ4); referenced in actin-binding, cell migration, and tissue signaling research literature.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eThe Glow Stack is supplied for laboratory research applications involving multi-peptide co-formulation studies. The three components are commonly referenced in published research involving:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCopper-peptide signaling and extracellular matrix research\u003c\/li\u003e\n\u003cli\u003eRegenerative pathway and tissue signaling models\u003c\/li\u003e\n\u003cli\u003eThymosin fragment biology and actin-binding research\u003c\/li\u003e\n\u003cli\u003eComparative peptide co-formulation stability studies\u003c\/li\u003e\n\u003cli\u003eMulti-component peptide pharmacokinetic profiling\u003c\/li\u003e\n\u003cli\u003eDermal and connective tissue research models\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGlow Stack\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCo-formulated research peptide blend\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eComposition\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGHK-Cu + BPC-157 + TB-500\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular classes\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCopper tripeptide · synthetic pentadecapeptide · thymosin beta-4 fragment\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eExtracellular matrix research, regenerative pathway research, tissue signaling, copper-peptide biology, thymosin fragment biology, multi-peptide co-formulation research\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEpitalon, Thymalin, Thymosin Alpha-1, KPV, Semax, Selank\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Glow Stack lot supplied by DISSOLV LABS undergoes a structured analytical workflow at the individual-component level and at the blended-formulation level to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePer-component purity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePer-component identity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCo-formulation compatibility verification\u003c\/strong\u003e across the blended lyophilizate\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSingle co-lyophilized blended vial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform lyophilized solid; faint blue-violet hue characteristic of the GHK-Cu copper complex\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-GLOW-001\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% per component (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat is the Glow Stack?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe Glow Stack is a co-formulated research peptide blend supplied by DISSOLV LABS. It combines GHK-Cu (copper tripeptide), BPC-157 (synthetic pentadecapeptide), and TB-500 (synthetic thymosin beta-4 fragment) into a single lyophilized vial as an analytical reference formulation for laboratory research use only.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat peptides does the Glow Stack contain?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThree components, each individually verified at ≥99% purity:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e — copper-binding tripeptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157\u003c\/strong\u003e — synthetic pentadecapeptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500\u003c\/strong\u003e — synthetic Thymosin Beta-4 fragment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhy are these three compounds blended together?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe three components occupy complementary positions within the regenerative-pathway and extracellular-matrix research literature: GHK-Cu in copper-peptide signaling, BPC-157 in regenerative pathway research, and TB-500 in actin-binding and cell migration research. Supplying them as a single co-lyophilized blend streamlines comparative laboratory work that would otherwise require reconstituting and combining three separate vials.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eIs the Glow Stack one vial or three?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe Glow Stack is supplied as a \u003cstrong\u003esingle co-lyophilized vial\u003c\/strong\u003e containing all three components in one blended formulation. Individual single-compound vials of GHK-Cu, BPC-157, and TB-500 are also available separately in the DISSOLV LABS catalog.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat category does the Glow Stack belong to?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe Glow Stack is classified as a co-formulated multi-peptide research blend within the regenerative-pathway and tissue-signaling research peptide category. It is supplied as a reference formulation for laboratory research professionals.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eEach of the three components is individually verified at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS) prior to co-lyophilization. Each blended lot is accompanied by a Certificate of Analysis covering all three components.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eEach Glow Stack lot is subjected to per-component RP-HPLC purity analysis, per-component HPLC-MS identity confirmation, co-formulation compatibility verification across the blended lyophilizate, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhy does the lyophilized powder have a blue tint?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe faint blue-violet hue is characteristic of the GHK-Cu copper complex and is an expected visual indicator of an intact copper-peptide component within the blend. Color intensity may vary slightly between lots.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eHow should the Glow Stack be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eHow is the Glow Stack reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe blended lyophilizate is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eIs the Glow Stack research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eYes. The Glow Stack supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting per-component purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWho should handle the Glow Stack?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe Glow Stack is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003ch2\u003eComponent Reference\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e — copper-binding tripeptide (Gly-His-Lys-Cu²⁺); extracellular matrix and tissue signaling research\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157\u003c\/strong\u003e — synthetic 15-amino-acid peptide; regenerative pathway and gastrointestinal research\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500\u003c\/strong\u003e — synthetic Thymosin Beta-4 fragment; actin-binding, cell migration, and tissue signaling research\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEpitalon\u003c\/strong\u003e — synthetic tetrapeptide research compound studied in telomerase and pineal pathway research\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThymalin\u003c\/strong\u003e — thymic peptide complex research compound\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThymosin Alpha-1\u003c\/strong\u003e — thymic peptide research compound\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKPV\u003c\/strong\u003e — synthetic tripeptide research compound (α-MSH C-terminal fragment)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSemax\u003c\/strong\u003e — synthetic heptapeptide neuropeptide research compound\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSelank\u003c\/strong\u003e — synthetic heptapeptide neuropeptide research compound\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"Dissolv Labs","offers":[{"title":"Default Title","offer_id":52101981536536,"sku":"DSL-GLOW-001","price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/GlowStack70mg.png?v=1779639000"},{"product_id":"klow-stack","title":"Klow Stack","description":"\u003c!-- =========================================================\n  KLOW STACK — DISSOLV LABS\n  Blended research peptide formulation:\n  BPC-157 + KPV + TB-500 + GHK-Cu\n  80 mg total blended peptide content, single lyophilized vial\n  Shopify product description — paste into the Code View\n  of the product description field.\n========================================================= --\u003e\n\n\u003ch2\u003eKlow Stack — Blended Research Peptide Formulation\u003c\/h2\u003e\n\u003cp\u003eThe DISSOLV LABS \u003cstrong\u003eKlow Stack\u003c\/strong\u003e is a four-component co-formulated research peptide blend pairing the regenerative-pathway components of our flagship Glow Stack with the addition of \u003cstrong\u003eKPV\u003c\/strong\u003e, a synthetic α-MSH C-terminal tripeptide commonly studied within melanocortin-pathway and inflammatory signaling research literature. Supplied as a single 80 mg lyophilized vial for qualified laboratory research professionals.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003eComposition:\u003c\/strong\u003e BPC-157 · KPV · TB-500 · GHK-Cu\u003cbr\u003e\n  \u003cstrong\u003eTotal peptide content:\u003c\/strong\u003e 80 mg blended\u003cbr\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% per component (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e Single co-lyophilized blended vial\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eFormulation Overview\u003c\/h2\u003e\n\u003cp\u003eThe Klow Stack expands the three-component regenerative-pathway research framework of the Glow Stack by introducing a fourth synthetic peptide — KPV — that brings melanocortin-receptor and α-MSH-pathway research into the same co-formulated reference vial. Each of the four components is individually verified at ≥99% purity prior to co-lyophilization.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eSynthetic pentadecapeptide (15 amino acids) derived from a sequence in body protection compound; commonly studied in regenerative pathway and gastrointestinal research models.\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cstrong\u003eKPV\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eSynthetic tripeptide (Lys-Pro-Val); C-terminal fragment of α-melanocyte-stimulating hormone (α-MSH); referenced in melanocortin pathway and inflammatory signaling research literature.\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eSynthetic peptide fragment of Thymosin Beta-4 (Tβ4); referenced in actin-binding, cell migration, and tissue signaling research literature.\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eCopper-binding tripeptide (Gly-His-Lys-Cu²⁺); referenced in extracellular matrix and tissue signaling research literature.\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eThe Klow Stack is supplied for laboratory research applications involving multi-peptide co-formulation studies across overlapping research domains. The four components are commonly referenced in published research involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eRegenerative pathway and tissue signaling research models\u003c\/li\u003e\n  \u003cli\u003eCopper-peptide signaling and extracellular matrix research\u003c\/li\u003e\n  \u003cli\u003eThymosin fragment biology and actin-binding research\u003c\/li\u003e\n  \u003cli\u003eMelanocortin receptor pharmacology and α-MSH-pathway research\u003c\/li\u003e\n  \u003cli\u003eInflammatory signaling research models\u003c\/li\u003e\n  \u003cli\u003eComparative multi-peptide co-formulation stability studies\u003c\/li\u003e\n  \u003cli\u003eMulti-component peptide pharmacokinetic profiling\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eKlow Stack\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCo-formulated four-component research peptide blend\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eComposition\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBPC-157 + KPV + TB-500 + GHK-Cu\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTotal peptide content\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e80 mg blended per vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular classes\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic pentadecapeptide · synthetic tripeptide (α-MSH fragment) · thymosin beta-4 fragment · copper tripeptide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRegenerative pathway research, melanocortin pathway research, inflammatory signaling, extracellular matrix research, thymosin fragment biology, multi-peptide co-formulation research\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEpitalon, Thymalin, Thymosin Alpha-1, Semax, Selank, LL-37\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eKlow Stack vs. Glow Stack\u003c\/h2\u003e\n\u003cp\u003eThe Klow Stack and Glow Stack share three components — BPC-157, TB-500, and GHK-Cu — operating within regenerative-pathway and extracellular-matrix research literature. The Klow Stack extends that framework by adding \u003cstrong\u003eKPV\u003c\/strong\u003e, a synthetic α-MSH C-terminal tripeptide that brings melanocortin-pathway and inflammatory-signaling research into the same blended reference vial.\u003c\/p\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eGlow Stack\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eKlow Stack\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eBPC-157\u003c\/td\u003e\n\u003ctd\u003e✓\u003c\/td\u003e\n\u003ctd\u003e✓\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eTB-500\u003c\/td\u003e\n\u003ctd\u003e✓\u003c\/td\u003e\n\u003ctd\u003e✓\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eGHK-Cu\u003c\/td\u003e\n\u003ctd\u003e✓\u003c\/td\u003e\n\u003ctd\u003e✓\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eKPV\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e✓\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eResearch domains\u003c\/td\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eTotal peptide content\u003c\/td\u003e\n\u003ctd\u003eStandard blend\u003c\/td\u003e\n\u003ctd\u003e80 mg blended\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Klow Stack lot supplied by DISSOLV LABS undergoes a structured analytical workflow at the individual-component level and at the blended-formulation level to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-component purity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-component identity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCo-formulation compatibility verification\u003c\/strong\u003e across the blended lyophilizate\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTotal peptide content quantification\u003c\/strong\u003e against the 80 mg specification\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSingle co-lyophilized blended vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTotal peptide content\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e80 mg blended (four-component)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform lyophilized solid; faint blue-violet hue characteristic of the GHK-Cu copper complex\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-KLOW-001\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% per component (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat is the Klow Stack?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe Klow Stack is a four-component co-formulated research peptide blend supplied by DISSOLV LABS. It combines BPC-157 (synthetic pentadecapeptide), KPV (synthetic α-MSH C-terminal tripeptide), TB-500 (synthetic thymosin beta-4 fragment), and GHK-Cu (copper tripeptide) into a single 80 mg lyophilized vial as an analytical reference formulation for laboratory research use only.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat peptides does the Klow Stack contain?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eFour components, each individually verified at ≥99% purity:\u003c\/p\u003e\n  \u003cul\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBPC-157\u003c\/strong\u003e — synthetic pentadecapeptide\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eKPV\u003c\/strong\u003e — synthetic α-MSH C-terminal tripeptide\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eTB-500\u003c\/strong\u003e — synthetic Thymosin Beta-4 fragment\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e — copper-binding tripeptide\u003c\/li\u003e\n  \u003c\/ul\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is the Klow Stack different from the Glow Stack?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe Klow Stack and Glow Stack share three components — BPC-157, TB-500, and GHK-Cu. The Klow Stack adds a fourth component, \u003cstrong\u003eKPV\u003c\/strong\u003e, expanding the research scope to include melanocortin-pathway and inflammatory-signaling research literature alongside the existing regenerative-pathway and extracellular-matrix domains. The Klow Stack is also specified at 80 mg total peptide content per vial.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat is the total peptide content?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003e\u003cstrong\u003e80 mg total blended peptide content\u003c\/strong\u003e per vial, distributed across the four components. Per-component ratios and individual masses are documented on the lot-specific Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs the Klow Stack one vial or four?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe Klow Stack is supplied as a \u003cstrong\u003esingle co-lyophilized vial\u003c\/strong\u003e containing all four components in one blended formulation. Individual single-compound vials of BPC-157, KPV, TB-500, and GHK-Cu are also available separately in the DISSOLV LABS catalog.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat is KPV?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eKPV is a synthetic tripeptide composed of the amino acids Lysine-Proline-Valine (Lys-Pro-Val). It is the C-terminal tripeptide fragment of α-melanocyte-stimulating hormone (α-MSH) and is referenced in published research literature involving melanocortin-pathway pharmacology and inflammatory signaling research models.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat category does the Klow Stack belong to?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe Klow Stack is classified as a co-formulated multi-peptide research blend spanning regenerative-pathway, extracellular-matrix, thymosin-fragment, and melanocortin-pathway research peptide categories. It is supplied as a reference formulation for laboratory research professionals.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach of the four components is individually verified at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS) prior to co-lyophilization. Each blended lot is accompanied by a Certificate of Analysis covering all four components and the 80 mg total content specification.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Klow Stack lot is subjected to per-component RP-HPLC purity analysis, per-component HPLC-MS identity confirmation, co-formulation compatibility verification across the blended lyophilizate, total peptide content quantification against the 80 mg specification, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhy does the lyophilized powder have a blue tint?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe faint blue-violet hue is characteristic of the GHK-Cu copper complex and is an expected visual indicator of an intact copper-peptide component within the blend. Color intensity may vary slightly between lots.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should the Klow Stack be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is the Klow Stack reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe blended lyophilizate is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs the Klow Stack research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. The Klow Stack supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting per-component purity, identity, total peptide content, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle the Klow Stack?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe Klow Stack is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eComponent Reference\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBPC-157\u003c\/strong\u003e — synthetic 15-amino-acid peptide; regenerative pathway and gastrointestinal research\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKPV\u003c\/strong\u003e — synthetic tripeptide (Lys-Pro-Val); α-MSH C-terminal fragment; melanocortin-pathway and inflammatory-signaling research\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTB-500\u003c\/strong\u003e — synthetic Thymosin Beta-4 fragment; actin-binding, cell migration, and tissue signaling research\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e — copper-binding tripeptide (Gly-His-Lys-Cu²⁺); extracellular matrix and tissue signaling research\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRelated Research Compounds \u0026amp; Stacks\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGlow Stack\u003c\/strong\u003e — three-component co-formulated research blend (GHK-Cu + BPC-157 + TB-500)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEpitalon\u003c\/strong\u003e — synthetic tetrapeptide research compound studied in telomerase and pineal pathway research\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThymalin\u003c\/strong\u003e — thymic peptide complex research compound\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThymosin Alpha-1\u003c\/strong\u003e — thymic peptide research compound\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSemax\u003c\/strong\u003e — synthetic heptapeptide neuropeptide research compound\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSelank\u003c\/strong\u003e — synthetic heptapeptide neuropeptide research compound\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLL-37\u003c\/strong\u003e — synthetic cathelicidin-derived peptide research compound\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"Dissolv Labs","offers":[{"title":"Default Title","offer_id":52101984846104,"sku":"DSL-KLOW-001","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/KlowStack80mg.png?v=1779639364"},{"product_id":"retatrutide-20mg","title":"Retatrutide 20mg","description":"\u003ch2\u003eRetatrutide — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is a synthetic investigational peptide referenced in the scientific literature as a single-molecule triple agonist at the \u003cstrong\u003eGLP-1\u003c\/strong\u003e, \u003cstrong\u003eGIP\u003c\/strong\u003e, and \u003cstrong\u003eglucagon\u003c\/strong\u003e receptor systems, supplied here in a 20 mg lyophilized vial format.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e 20mg lyophilized vial, sealed amber glass\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is classified within the multi-receptor incretin research peptide family. It is engineered as a unimolecular agonist that concurrently engages three structurally related receptor systems: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon.\u003c\/p\u003e\n\n\u003cp\u003eThe 20 mg vial format offers a higher peptide content per vial than the 10 mg specification, suited to laboratory workflows requiring expanded comparative or repeat-assay material. Within peer-reviewed publications, Retatrutide is positioned as the triple-agonist endpoint of the unimolecular incretin research lineage.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eRetatrutide has been investigated in published research literature and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eComparative incretin receptor pharmacology\u003c\/li\u003e\n  \u003cli\u003eUnimolecular multi-agonist peptide structure–activity research\u003c\/li\u003e\n  \u003cli\u003eEnergy substrate signaling pathway models\u003c\/li\u003e\n  \u003cli\u003eGlucose homeostasis and metabolic signaling research\u003c\/li\u003e\n  \u003cli\u003eComparative peptide pharmacokinetics and stability profiling\u003c\/li\u003e\n  \u003cli\u003eReceptor binding affinity and selectivity studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRetatrutide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUnimolecular triple agonist (GLP-1 \/ GIP \/ glucagon)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin-class multi-receptor agonist research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin biology, metabolic signaling, peptide pharmacology, receptor agonism\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTirzepatide, Semaglutide, Cagrilintide, Cagrisema, Survodutide, Mazdutide, AOD9604, HGH Fragment 176-191\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Retatrutide lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e20mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-RETA-0020\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does the 20 mg vial differ from the 10 mg vial?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe 10 mg and 20 mg formats are analytically identical. They differ only in total peptide content per vial.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Retatrutide differ from Tirzepatide and Semaglutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is described as a single-receptor GLP-1 agonist, Tirzepatide as a dual GLP-1\/GIP agonist, and Retatrutide as a unimolecular triple agonist engaging GLP-1, GIP, and glucagon receptors.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Retatrutide at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Retatrutide lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Retatrutide be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Retatrutide reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Retatrutide research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Retatrutide supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrisema\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSurvodutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eMazdutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eAOD9604\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eHGH Fragment 176-191\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"DISSOLV LABS","offers":[{"title":"Default Title","offer_id":52102992199960,"sku":"DSL-RETA-0020","price":54.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Retatrutide_20mg.png?v=1779524289"}],"url":"https:\/\/dissolv.com\/collections\/featured-collection.oembed","provider":"Dissolv Labs","version":"1.0","type":"link"}